Home > Cardiology > ECMO-resuscitation tied to better survival in out-of-hospital cardiac arrest

ECMO-resuscitation tied to better survival in out-of-hospital cardiac arrest

Journal
The Lancet
Conference
AHA 2020
Reuters Health - 18/11/2020 - Patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation are far more likely to survive when treated with extracorporeal membrane oxygenation (ECMO)-facilitated resuscitation than with standard advanced cardiac life support (ACLS), a small trial finds. With 6 out of 14 patients randomly assigned to receive ECMO surviving versus 1 of 15 who received standard ACLS, the benefits appeared so dramatic that the phase 2 trial was halted early after enrolling just 30 of the planned 165 patients, according to the report published in The Lancet and presented at the American Heart Association's Scientific Sessions 2020, held virtually this year. The trial, known as the Advanced Reperfusion Strategies for Refractory Cardiac Arrest (ARREST), was funded by the National Heart, Lung and Blood Institute. NHLBI opted to end the trial after a unanimous recommendation from the Data and Safety Monitoring Board. "Having an ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on